TY - JOUR
T1 - Allele-Specific Cytokine Responses at the HLA-C Locus: Implications for Psoriasis
AU - Hundhausen, Christian
AU - Bertoni, Anna
AU - Mak, Rose K.
AU - Botti, Elisabetta
AU - Di Meglio, Paola
AU - Clop, Alex
AU - Laggner, Ute
AU - Chimenti, Sergio
AU - Hayday, Adrian C.
AU - Barker, Jonathan N.
AU - Trembath, Richard C.
AU - Capon, Francesca
AU - Nestle, Frank O.
PY - 2012/3
Y1 - 2012/3
N2 - Psoriasis is an inflammatory skin disorder that is inherited as a complex trait. Genetic studies have repeatedly highlighted HLA-C as the major determinant for psoriasis susceptibility, with the Cw*0602 allele conferring significant disease risk in a wide range of populations. Despite the potential importance of HLA-C variation in psoriasis, either via an effect on peptide presentation or immuno-inhibitory activity, allele-specific expression patterns have not been investigated. Here, we used reporter assays to characterize two regulatory variants, which virtually abolished the response to tumor necrosis factor (TNF)-alpha (rs2524094) and IFN-gamma (rs10657191) in HLA-Cw*0602 and a cluster of related alleles. We validated these findings through the analysis of HLA-Cw*0602 expression in primary keratinocytes treated with TNF-alpha and IFN-gamma. Finally, we showed that HLA-Cw*0602 transcripts are not increased in psoriatic skin lesions, despite highly elevated TNF-alpha levels. Thus, our findings demonstrate the presence of allele-specific differences in HLA-C expression and indicate that HLA-Cw*0602 is unresponsive to upregulation by key proinflammatory cytokines in psoriasis. These data pave the way for functional studies into the pathogenic role of the major psoriasis susceptibility allele.
AB - Psoriasis is an inflammatory skin disorder that is inherited as a complex trait. Genetic studies have repeatedly highlighted HLA-C as the major determinant for psoriasis susceptibility, with the Cw*0602 allele conferring significant disease risk in a wide range of populations. Despite the potential importance of HLA-C variation in psoriasis, either via an effect on peptide presentation or immuno-inhibitory activity, allele-specific expression patterns have not been investigated. Here, we used reporter assays to characterize two regulatory variants, which virtually abolished the response to tumor necrosis factor (TNF)-alpha (rs2524094) and IFN-gamma (rs10657191) in HLA-Cw*0602 and a cluster of related alleles. We validated these findings through the analysis of HLA-Cw*0602 expression in primary keratinocytes treated with TNF-alpha and IFN-gamma. Finally, we showed that HLA-Cw*0602 transcripts are not increased in psoriatic skin lesions, despite highly elevated TNF-alpha levels. Thus, our findings demonstrate the presence of allele-specific differences in HLA-C expression and indicate that HLA-Cw*0602 is unresponsive to upregulation by key proinflammatory cytokines in psoriasis. These data pave the way for functional studies into the pathogenic role of the major psoriasis susceptibility allele.
U2 - 10.1038/jid.2011.378
DO - 10.1038/jid.2011.378
M3 - Article
SN - 1523-1747
VL - 132
SP - 635
EP - 641
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 3
ER -